Literature DB >> 15583073

White-coat hypertension and risk of stroke: do the data really tell us what we need to know?

Paul W Franks.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15583073     DOI： 10.1161/01.HYP.0000151621.03913.f3

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

1.  Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yusuke Ishikawa; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-25       Impact factor: 3.738

2.  Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry.

Authors:  In Sook Kang; Wook Bum Pyun; Jinho Shin; Sang-Hyun Ihm; Ju Han Kim; Sungha Park; Kwang-Il Kim; Woo-Shik Kim; Soon Gil Kim; Gil Ja Shin
Journal:  Korean Circ J       Date:  2016-01-18       Impact factor: 3.243

3.  Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.

Authors:  Jack C de la Torre
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-12-03

4.  The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: a meta-analysis involving 13,949 individuals.

Authors:  Karani Santhanakrishnan Vimaleswaran; Jian'an Luan; Gitte Andersen; Y Li Muller; Eleanor Wheeler; Ema C Brito; Stephen O'Rahilly; Oluf Pedersen; Leslie J Baier; William C Knowler; Inês Barroso; Nicholas J Wareham; Ruth J F Loos; Paul W Franks
Journal:  J Appl Physiol (1985)       Date:  2008-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.